KR101252630B1 - Useful composition for growth and development of children and youths - Google Patents
Useful composition for growth and development of children and youths Download PDFInfo
- Publication number
- KR101252630B1 KR101252630B1 KR1020120074139A KR20120074139A KR101252630B1 KR 101252630 B1 KR101252630 B1 KR 101252630B1 KR 1020120074139 A KR1020120074139 A KR 1020120074139A KR 20120074139 A KR20120074139 A KR 20120074139A KR 101252630 B1 KR101252630 B1 KR 101252630B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- growth
- children
- weight
- Prior art date
Links
- 230000012010 growth Effects 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 238000011161 development Methods 0.000 title claims abstract description 12
- 239000000284 extract Substances 0.000 claims abstract description 94
- 239000000843 powder Substances 0.000 claims abstract description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 17
- 239000011575 calcium Substances 0.000 claims abstract description 17
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 17
- 241001474374 Blennius Species 0.000 claims abstract description 12
- 230000001737 promoting effect Effects 0.000 claims abstract description 12
- 230000036541 health Effects 0.000 claims abstract description 5
- 235000005078 Chaenomeles speciosa Nutrition 0.000 claims abstract description 4
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 4
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 4
- 235000017831 Pseudocydonia sinensis Nutrition 0.000 claims abstract description 4
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 4
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 4
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 4
- 235000013361 beverage Nutrition 0.000 claims abstract description 4
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 4
- 235000020737 peppermint extract Nutrition 0.000 claims abstract description 4
- 229940069774 quince extract Drugs 0.000 claims abstract description 4
- 244000251905 Pseudocydonia sinensis Species 0.000 claims abstract 2
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 12
- 244000000231 Sesamum indicum Species 0.000 claims description 4
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 4
- 240000002045 Guettarda speciosa Species 0.000 claims description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 3
- 210000004207 dermis Anatomy 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- 229940069445 licorice extract Drugs 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 13
- 230000004060 metabolic process Effects 0.000 abstract description 6
- 239000001522 artemisia absinthium l. herb extract Substances 0.000 abstract description 2
- 229930014626 natural product Natural products 0.000 abstract description 2
- 230000009645 skeletal growth Effects 0.000 abstract description 2
- 229940119569 wormwood extract Drugs 0.000 abstract description 2
- 240000001810 Angelica gigas Species 0.000 abstract 1
- 235000018865 Angelica gigas Nutrition 0.000 abstract 1
- 241000282994 Cervidae Species 0.000 abstract 1
- 235000005903 Dioscorea Nutrition 0.000 abstract 1
- 244000281702 Dioscorea villosa Species 0.000 abstract 1
- 235000000504 Dioscorea villosa Nutrition 0.000 abstract 1
- 241000237858 Gastropoda Species 0.000 abstract 1
- 241000202807 Glycyrrhiza Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 240000003582 Platycodon grandiflorus Species 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000021028 berry Nutrition 0.000 abstract 1
- 235000004879 dioscorea Nutrition 0.000 abstract 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 abstract 1
- 102000018997 Growth Hormone Human genes 0.000 description 18
- 108010051696 Growth Hormone Proteins 0.000 description 18
- 239000000122 growth hormone Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 11
- 240000006891 Artemisia vulgaris Species 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 8
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 7
- 102100037852 Insulin-like growth factor I Human genes 0.000 description 7
- 235000016709 nutrition Nutrition 0.000 description 7
- 239000013641 positive control Substances 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 239000011574 phosphorus Substances 0.000 description 4
- 229910052698 phosphorus Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000003797 essential amino acid Substances 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 235000021067 refined food Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 240000000425 Chaenomeles speciosa Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000199900 Laminariales Species 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 208000021017 Weight Gain Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000006694 eating habits Nutrition 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000004260 weight control Methods 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000397426 Centroberyx lineatus Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 101000868151 Rattus norvegicus Somatotropin Proteins 0.000 description 1
- 241000015177 Saccharina japonica Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000021061 dietary behavior Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
본 발명은 어린이 및 청소년 성장 발육에 도움을 주는 조성물에 관한 것이다.
The present invention relates to a composition that aids in the growth development of children and adolescents.
현대 사회는 식량 생산의 증대와, 경제 성장과 다문화로 인한 식습관의 변화는, 이전의 허기를 해결하려는 식품의 일차적인 기능 이외에 좀 더 맛있는 식품, 오래 두고 먹을 수 있는 식품, 간편하게 먹을 수 있는 식품 등에 대하여 관심을 갖고 연구를 하게 되었고, 그 결과 식품 첨가물의 개발과 더불어 인스턴트 식품, 정제가공식품이 발달하게 되었다. In modern society, the increase in food production, economic growth, and changes in eating habits caused by multiculturalism are not only the primary functions of foods to solve the previous hunger, but also more delicious foods, long-lasting foods, and easy-to-eat foods. Interested in the research, as a result of the development of food additives, the development of instant foods, processed foods.
이러한 각종 가공식품은 시각과 미각적인 기호성을 충족시키고, 저장성이 향상되었으나, 이에 상응하는 다양한 부작용이 나타나고 있는 실정이다. 즉 가공 식품의 제조 과정 중 미량의 영양소가 소실되어, 영양의 불균형이 초래되고, 화학조미료, 발색제 방부제 등의 과다사용에 의하여 체내의 항상성을 왜곡시킴으로써, 유아 또는 성장기의 어린아이의 성장을 저해하고, 면역력을 떨어뜨리며, 성인병의 조기발생을 촉진시키는 부작용이 나타나고 있다. These various processed foods meet the visual and taste palatability, and the shelf life is improved, but various side effects appear. In other words, traces of nutrients are lost during the manufacturing process of processed foods, resulting in nutritional imbalances, and distorting the homeostasis of the body by overuse of chemical seasonings, colorants, and preservatives, thereby inhibiting the growth of infants and young children. In addition, side effects have been shown to reduce immunity and promote the early development of adult diseases.
성장을 의학적으로 정의하면, 성숙에 수반되는 크기의 변화라고 할 수 있으며, 특히 소아의 성장이라 함은 신장의 증가뿐만 아니라 신체의 각 기관의 크기와 기능의 증대를 포괄적으로 포함하는 개념이지만, 일반적으로는 신장의 증가에 국한되어 사용된다. 이 같은 신장의 증가는 연골조직의 합성, 골격길이 성장 및 골격조직의 광범위한 증식을 포함하는 골격대사를 통하여 이루어지는데, 이러한 신장 증가는 소아의 건강상태, 영양, 호르몬, 유전적 배경을 나타내는 예민한 지표로서 활용되고 있다. Medically defined growth is a change in size that accompanies maturity. In particular, growth in children is a concept that encompasses not only an increase in height but also an increase in the size and function of each organ in the body, It is used only for the increase in height. This increase is achieved through skeletal metabolism, which includes the synthesis of cartilage, skeletal length growth, and extensive growth of skeletal tissue, which is a sensitive indicator of the health, nutrition, hormones, and genetic background of children. It is utilized as.
일반적으로, 사람의 성장을 살펴볼 때, 대개 유전적 영향이 가장 크게 영향을 미치는 것으로 여겨지고 있으나, 실제로는 유전적인 영향은 23% 정도 밖에 해당되지 않으며, 나머지 77%는 후천적 영향에 의해 결정되는데, 구체적으로는 영양 31%, 운동 20%, 환경이 16%, 기타 10% 정도라는 연구결과가 보고되었다. 따라서, 성장을 촉진시키기 위해서는, 인스턴트 식품의 섭취를 줄이고 영양의 균형화, 적절한 운동, 오염 환경의 개선 등이 요구되지만, 이 중에서도 영향의 균형화가 가장 중요한 요인으로 지적되고 있다. In general, when looking at human growth, genetic influences are generally considered to have the greatest impact, but in practice, genetic influence is only about 23%, and the remaining 77% is determined by acquired effects. For example, 31% of nutrition, 20% of exercise, 16% of environment, and 10% of other studies were reported. Therefore, in order to promote growth, it is required to reduce the intake of instant foods, to balance nutrition, to exercise appropriately, to improve the pollution environment, etc. Among these, the balance of influence is pointed out as the most important factor.
이처럼 영향의 균형화를 달성하여 궁극적으로는 성장을 촉진시키기 위하여는, 일반적으로는 식생활 행태를 전적으로 변화시켜야 하지만, 이는 현실적으로 불가능하기 때문에, 이의 대안으로서, 성장촉진을 위한 건강보조식품을 섭취하는 방법이 제기되었고, 이에 따라, 영양의 균형을 보조하여 성장을 촉진할 수 있는 다양한 건강보조식품이 개발되고 있는 실정이다. In order to achieve this balance of influence and ultimately promote growth, it is generally necessary to change dietary behavior entirely, but since this is not practically possible, alternatives to eating health supplements to promote growth As a result, various health supplements are being developed that can support the nutritional balance and promote growth.
예를 들어, 대한민국 특허등록 제 0715653호에는 해조칼슘, 식물추출물, 클로렐라추출물, 맥아추출물 및 초유분말 등을 포함하는 건강보조식품을 개시하고, 대한민국 특허등록 제 0601265호에는 인진쑥을 개시하고 있으며, 대한민국 특허등록 278206호에는 홍화씨, 두충, 백복령, 복분자, 토사자, 및 녹각과 칼슘 등을 포함하는 건강보조식품을 개시하고 있다. For example, Korean Patent Registration No. 0715653 discloses health supplements including seaweed calcium, plant extracts, chlorella extracts, malt extracts and colostrum powder, and Korean Patent Registration No. 0601265 discloses Injin mugwort. Patent registration No. 278206 discloses health supplements including safflower seed, tofu, baekbokyeong, bokbunja, earth and sand, and green tea and calcium.
그러나, 이러한 종래의 건강보조식품 또는 성장 촉진용 의약품은 골격의 성장만을 지나치게 중요시한 나머지, 일시적으로나마 복용자의 체내 대사를 비정상적으로 활성화시킬 수도 있다는 문제점이 제기되어, 실질적으로는 많이 활용되지 못하고 있는 실정이다.
However, such conventional dietary supplements or growth promoting drugs are so important that only the growth of the skeleton is too important, and may temporarily activate abnormally the metabolism of the user's body, which is not practically utilized much. to be.
따라서, 본 발명은 천연물을 이용하여 어린이 및 청소년의 골격 성장과 체내 대사를 균형적으로 활성화시켜 발육에 도움이 되는 조성물을 개발하는데 목적이 있다.
Therefore, an object of the present invention is to develop a composition that is useful for the development by balanced activation of skeletal growth and metabolism in children and adolescents using natural products.
본 발명은 상기와 같은 과제를 해결하기 위하여, 다슬기 분말, 다시마 추출물, 인진쑥 추출물, 클로렐라, 해조 칼슘을 유효성분으로 함유하며, 상기 추출물 총 중량 100 중량%에 대하여 1~20 중량%의 다슬기 분말, 1~20 중량%의 다시마 추출물, 10~30 중량%의 인진쑥 추출물, 10~30 중량%의 클로렐라, 10~30 중량%의 해조 칼슘을 포함하는 것을 특징으로 하는 어린이 및 청소년 성장 발육에 도움을 주는 조성물을 제공한다. The present invention, in order to solve the above problems, sage powder, kelp extract, jinjin wormwood extract, chlorella, seaweed calcium as an active ingredient, 1 to 20% by weight of the scotch powder with respect to the total weight of the extract 100% by weight, Helping children and adolescents grow, characterized in that it contains 1 to 20% by weight of kelp extract, 10 to 30% by weight of phosphorus mugwort extract, 10 to 30% by weight of chlorella, and 10 to 30% by weight of seaweed calcium. To provide a composition.
본 발명의 또 다른 실시예에 따르면, 산약 추출물, 오가피 추출물, 맥아 추출물, 진피 추출물, 나복자 추출물, 탱자 추출물, 오미자 추출물, 복분자 추출물, 용안 추출물, 당귀 추출물, 두충추출물, 모과 추출물, 속단추추출물, 백강잠추출물, 갈근추출물, 길경추출물, 대추추출물, 감초추출물, 박하추출물, 건장추출물로부터 선택되는 하나 이상의 성분을 더 포함하는 것을 특징으로 하는 어린이 및 청소년 성장 발육에 도움을 주는 조성물을 제공한다.According to another embodiment of the present invention, mountain extract, ogapi extract, malt extract, dermis extract, nabokja extract, tanza extract, Schisandra extract, bokbunja extract, longan extract, Angelica extract, tofu extract, Chinese quince extract, soybean extract, It provides a composition for helping children and adolescents growth development, characterized in that it further comprises one or more components selected from Baeksijam extract, root extract, Gilge extract, jujube extract, licorice extract, peppermint extract, dried extract.
상기에 있어서, 조성물은 분말, 과립, 정제, 캡슐 또는 음료 형태인 건강 기능성 식품인 것을 특징으로 하는 어린이 및 청소년 성장 발육에 도움을 주는 조성물을 제공한다.
In the above, the composition provides a composition for helping children and adolescent growth development, characterized in that the health functional food in the form of powder, granules, tablets, capsules or beverages.
본 발명에 따라 다슬기 분말, 다시마 추출물, 인진쑥 추출물, 클로렐라, 해조 칼슘을 이용하여 제조된 조성물은 어린이 및 청소년의 골격 성장과 체내 대사를 균형적으로 활성화시켜 어린이 및 청소년 성장 발육에 도움이 된다.
According to the present invention, the composition prepared using the powder of sesame seed, kelp extract, jinjin mugwort extract, chlorella, and seaweed calcium helps to promote the growth of children and adolescents by balancing the metabolic and body metabolism of children and adolescents.
본 발명에 따른 조성물은 다슬기, 다시마, 인진쑥, 클로렐라, 해조 칼슘을 이용하여 제조된다.The composition according to the present invention is prepared using sesame seed, kelp, jinjin worm, chlorella, seaweed calcium.
본 발명의 유효성분인 다슬기는 단백질과, 철분, 탄수화물이 풍부한 반면 총 지질은 그 함량이 낮은 편이다. 특히 단백질은 알기닌, 라이신을 비롯한 16종의 아미노산으로 구성되어 있다고 알려져 있으며, 그 중에서 알기닌 산이 총 아미노산의 7.74%를 차지하고 있어 다른 어패류에 비해서 알기닌 산이 풍부하다고 알려져 있다. The active ingredient of the present invention, the plural group is rich in protein, iron and carbohydrates, while the total lipid is low. In particular, proteins are known to be composed of 16 kinds of amino acids, including arginine and lysine. Among them, arginine acid accounts for 7.74% of total amino acids, which is known to be richer in arginine acid than other fish and shellfish.
상기의 알기닌 산은 체내 단백질을 구성하는 20가지 아미노산 중 하나로서 The arginine acid is one of the 20 amino acids constituting the protein in the body
NH+ 기를 함유한 염기성으로 성인에게는 체내 합성이 되는 비필수 아미노산이지만, 성장호르몬을 방출하는 소아에게는 체내 합성이 충분히 되지 않아 필수아미노산으로 인정되고 있으며, 면역반응과 관련하여 중요한 역할을 하고 있다.그 기능으로는 성장호르몬 촉진, 혈관 확장성분인 산화질소(nitric oxide, NO)의 전구성분, 면역세포 유지에 도움을 주는 기능을 한다. It is a non-essential amino acid that contains NH + groups and is a non-essential amino acid that is synthesized in the body in adults, but it is recognized as an essential amino acid due to insufficient synthesis in the body in children who release growth hormone, and plays an important role in the immune response. Functions include promoting growth hormone, progenitors of nitric oxide (NO), which are vasodilators, and helping to maintain immune cells.
한편, 본 발명의 유효성분인 인진쑥은 열을 내리고 습을 제거하는 효과가 있어, 습열 황달, 소변이 잘 나오지 않는 증상을 치료하는데 효과가 있는 것으로 알려져 있는데, 이의 약리작용으로는 간 손상 억제작용(이치호 외 2명, 한국축산식품학회 제22차 추계학술발표회 초록집, 1998), 항암효과(정차권 외 3명, 한국식품과학회 춘계 공동학술발표회 초록집, 1998), 항산화 작용, 혈중지질 감소 및 간기능 개선효과(한은경 외 4명, 한국식품영양학회 춘계학술대회, 1997), 항돌연변이 효과(최동성 외 5명, 한국생물공학회지, 2000), 항균효과(장매희 및 조연희, 인진쑥, 사철쑥, 사자발쑥의 정유성분 및 항균효과), 성장촉진 또는 성장 호르몬 분비 촉진 효과(대한민국 등록특허 0601265) 등이 알려져 있다.On the other hand, Injin mugwort as an active ingredient of the present invention is effective in lowering heat and eliminating moistness, and is known to be effective in treating symptoms of moist jaundice and urine, but its pharmacological action inhibits liver damage ( Lee Chi-ho and two others, Korean Society of Food Science and Nutrition, 22nd Autumn Conference, 1998), anticancer effect (3 others including Jung-Gwon Jung, Korean Society of Food Science and Technology Spring Conference, 1998), antioxidant activity, blood lipid reduction and liver function improvement Effects (Han Eun-kyung and 4 others, Korean Society of Food and Nutrition, Spring Conference, 1997), antimutagenic effects (Cho, Dong-Sung et al., Korean Journal of Biotechnology and Bioengineering, 2000) Ingredients and antibacterial effects), growth promoting or growth hormone secretion promoting effect (Korean Patent 0601265) and the like are known.
인진쑥 추출물은 30~50 메쉬로 분쇄한 인진쑥을 3 내지 6배 중량 비의 물 또는 유기용매 중에서 48 내지 72시간 동안 초음파 분쇄기를 이용하여 추출하거나 4 내지 7 시간 동안 환류 한 다음, 필요에 따라 0.1 내지 10 ㎛ 필터로 여과한 후 60 내지 80℃ 온도에서 24 내지 60시간 동안 5 내지 10 배 감압 농축하여 30℃ 이하로 냉각하여 얻은 추출물을 동결 건조하여 얻을 수 있다.Phosphorus mugwort extract is extracted by using an ultrasonic grinder for 48 to 72 hours or refluxed for 4 to 7 hours in water or an organic solvent of 3 to 6 times the weight ratio of pulverized mugwort pulverized to 30-50 mesh, and then 0.1 to The extract obtained by filtration with a 10 μm filter and concentrated under reduced pressure 5 to 10 times at 60 to 80 ° C. for 24 to 60 hours and cooled to 30 ° C. or less may be obtained by freeze drying.
다시마(Laminaria japonica)는 갈조식물문(Phaepphyta) 갈조강(Phaeophyceae) 다시마목(Laminariales) 다시마과(Laminariaceae)에 속하는 다년생 대형 갈조류로, 참다시마, 해대 또는 해곤포라고도 불리운다. 외관상 엽상부, 줄기, 뿌리로 구분되며, 엽상부는 띠모양으로 길고, 엽사부의 중앙부분은 두터운 중대부를 이루며, 중대부의 양 가는 세로로 홈이 있다. 줄기는 보통 원주상이며 직립하며, 뿌리는 줄기의 하부에서 차상으로 분지하는 수지상의 형태를 나타낸다. 한대, 아한대의 연안에 분포하는 한행성 해조류로서, 대한미국에서는 동해안 북부, 원산 이북의 함경북도에서 자생하며, 동해안 남부와 남해안의 완도 등지에서 양식을 한다. Laminaria japonica is a perennial large brown algae belonging to the Laminariales of the Laminariales, Phaeophyceae, Phaepphyta. Appearance is divided into lobe, stem, and root, the lobe is long in the shape of a band, the central part of the lobe part forms a thick middle part, and both sides of the middle part are vertically grooved. Stems are usually columnar, upright, and the roots are dendritic, branching from the bottom of the stem to the tea phase. It is a marine algae distributed along the coast of Korea and the suburbs. It grows in the north coast of the east coast, north of Wonsan and north of Hamgyong, and grows in the south of the east coast and Wando on the south coast.
클로렐라는 광합성에 의하여 증식하는 단세포식물로 50~60%가 단백질, 15~20%가 탄수화물이며, 이 외에 엽록소, 비타민, 미네랄, 식이섬유 등과 같은 영양소가 풍부하다. 클로렐라엑기스는 다당체나 핵산 관련물질이 그 주성분이며, 1일 2g 정도의 클로렐라를 섭취하는 것만으로 단백질의 효율적인 섭취가 가능하다. 클로렐라의 단백질 중에 함유된 핵산은 성장 촉진효과를 가지고 있다. 또한 지질은 30% 정도가 리놀레인산이고, 15% 정도가 팔미틴산이며, 탄수화물도 헤미셀룰로오스를 많이 함유하고 있다.Chlorella is a single-celled plant that grows through photosynthesis, with 50-60% protein and 15-20% carbohydrates, as well as nutrients such as chlorophyll, vitamins, minerals and dietary fiber. Chlorella extract is composed of polysaccharides and nucleic acid-related substances, and it is possible to efficiently consume protein by simply ingesting 2g of chlorella per day. Nucleic acid contained in the protein of chlorella has a growth promoting effect. In addition, about 30% of the lipids are linoleic acid, 15% is palmitic acid, and carbohydrates also contain a lot of hemicellulose.
특히 클로렐라 특이성분으로 알려진 CGH(Chlorella growth factor)는 동물 또는 미생물의 성장 촉진 효과를 갖는 물질로 압도적으로 많은 단백질(57.3%)을 함유하며, 세포 내의 단백질 합성에 중추적인 역할을 하는 주요 소기관인 리보솜(Ribosom)과 에너지(ATP)생성 소기관인 미토콘드리아(Mitocondria)의 구조를 유지 및 복원함으로써 세포를 재생시켜주는 성분으로 알려져 있다.In particular, Chlorella growth factor (CGH), known as chlorella-specific ingredient, is a substance that promotes the growth of animals or microorganisms and contains overwhelmingly large amounts of protein (57.3%) and is a major organelle that plays a pivotal role in protein synthesis in cells. It is known as a component that regenerates cells by maintaining and restoring the structure of mitochondria, which are organelles (Ribosom) and energy (ATP).
칼슘은 인체 내에 가장 많이 함유되어 있는 무기질로 체중의 1~2%를 차지하며 이중 99%는 주로 치아와 골격을 형성하고, 나머지 1%는 혈액, 세포내, 외액 등에 존재하면서 인체에 중요한 생리적 조절기능을 담당하고 있다. 주된 기능으로는 근육의 수축, 신경자극 전달, 혈관의 수축과 이완 등에 관여하며, 혈액응고를 촉진하며, 효소의 활성화를 통해 세포내 대사과정을 조절한다. Calcium is the most abundant mineral in the human body, accounting for 1 ~ 2% of body weight, of which 99% mainly forms teeth and skeleton, and the remaining 1% is present in the blood, intracellular, and external fluids. It is in charge of function. Its main functions include muscle contraction, neurostimulatory transmission, blood vessel contraction and relaxation, promote blood coagulation, and regulate intracellular metabolic processes through the activation of enzymes.
해조칼슘은 칼슘함량이 30% 이상인 천연칼슘으로 무미, 무취하며 유분 및 수분흡수력이 우수한 벌집형 다공질 구조로 소화흡수율이 우수하고 완충능력이 탁월하여 입안의 젖산을 중화하여 충치를 예방하는 기능이 있다. 또한 이물감이 없으며, 중금속함량이 매우 낮고 기타 무기질 함량이 많아 기존 칼슘제의 대체 원료로도 각광 받고 있다 Seaweed calcium is a natural calcium with 30% or more calcium content. It is tasteless, odorless, honeycomb porous structure with excellent oil and water absorption ability. It has excellent digestion absorption rate and excellent buffering ability, which neutralizes lactic acid in the mouth to prevent tooth decay. . In addition, it has no foreign matter, and has a very low heavy metal content and high mineral content, and is also attracting attention as an alternative raw material for calcium.
본 발명의 조성물은 인진쑥 추출물, 다슬기 분말, 다시마 추출물, 클로렐라, 해조 칼슘을 유효성분으로 함유하며, 상기 추출물 총 중량 100 중량%에 대하여 10~30 중량%의 인진쑥 추출물, 1~20 중량%의 다슬기 분말, 1~20 중량%의 다시마 추출물, 10~30 중량%의 클로렐라, 10~30 중량%의 해조 칼슘을 포함하는 것을 특징으로 한다.The composition of the present invention contains the ginsujin mugwort extract, marshmallow powder, kelp extract, chlorella, seaweed calcium as an active ingredient, 10-30% by weight of the ginsujin mugwort extract, 1-20% by weight Powder, 1 to 20% by weight of kelp extract, 10 to 30% by weight of chlorella, characterized in that it comprises 10 to 30% by weight of seaweed calcium.
상기 추출물은 액상, 고상, 분말상 등 어떠한 형태도 가능하고 특별히 제한되지 않는다. 고상 또는 분말상으로 제조된 추출물은 적절한 용매에 배합하여 액상 조성물로 제조할 수 있다.The extract may be in any form, such as liquid, solid or powder, and is not particularly limited. Extracts prepared in solid or powder form may be formulated in a suitable solvent to form a liquid composition.
또한 본 발명의 조성물은 필요에 따라 산약 추출물, 오가피 추출물, 맥아 추출물, 진피 추출물, 나복자 추출물, 탱자 추출물, 오미자 추출물, 복분자 추출물, 용안 추출물, 당귀 추출물, 두충추출물, 모과 추출물, 속단추추출물, 백강잠추출물, 갈근추출물, 길경추출물, 대추추출물, 감초추출물, 박하추출물, 건장추출물로부터 선택되는 하나 이상의 성분을 더 포함할 수 있다.In addition, the composition of the present invention, if necessary, acid extract, Ogapi extract, malt extract, dermis extract, nabokja extract, tanza extract, Schisandra extract, bokbunja extract, longan extract, Angelica extract, sesame extract, Chinese quince extract, Sokcho extract, white squirt It may further include one or more components selected from extracts, root extracts, gildo extracts, jujube extracts, licorice extracts, peppermint extracts, dried extract.
본 발명의 조성물은 분말, 과립, 정제, 캡슐 또는 음료 형태인 건강 기능 식품형태로 제공될 수 있으나, 이들로 한정되는 것은 아니고 복용이 가능한 임의의 형태이면 가능하다.
The composition of the present invention may be provided in the form of a health functional food in the form of powder, granules, tablets, capsules or beverages, but is not limited thereto and may be any form that can be taken.
이하에서는 본 발명의 실시예에 의하여 더욱 상세히 설명한다. 그러나 본 발명이 하기 실시예에 의하여 한정되는 것은 아니다.
Hereinafter will be described in more detail by the embodiment of the present invention. However, the present invention is not limited by the following examples.
<< 제조예Manufacturing example 1> 다슬기 분말의 제조 1> Preparation of Swallowtail Powder
다슬기를 채취한 다음 불순물을 지체 배출시키도록 상온에서 방치시킨 다음, 소금물에 일정시간 동안 담가두어 2차로 불순물을 제거한 후, 깨끗한 물로 세척하고 소정시간을 방치한 다음 끓는 물에서 다슬기의 뚜껑이 나오도록 5~10분간 가열한 상태에서 깨끗한 물로 세척하고 건조기에서 건조한 후, 상온에서 냉각시켜 분쇄하여 다슬기 분말을 얻었다.
After collecting the mulberry, leave it at room temperature to discharge the impurities, and soak in salt water for a certain time to remove the secondary, then wash with clean water, leave a predetermined time, and then remove the lid of boiling water from boiling water After heating for 5 to 10 minutes in a state of washing with clean water, dried in a drier, cooled to room temperature and pulverized to obtain a fine powder.
<< 제조예Manufacturing example 2> 2> 인진쑥Inosugi 추출물 분말의 제조 Preparation of Extract Powder
40 메쉬로 분쇄한 인진쑥을 5배 중량 비의 물에서 48시간 동안 초음파 분쇄기를 이용하여 추출하거나 4 시간 동안 환류 한 다음, 필요에 따라 0.1 내지 10 ㎛ 필터로 여과한 후 60 내지 80℃ 온도에서 48시간 동안 5배 감압 농축하여 30℃ 이하로 냉각하여 얻은 추출물을 동결 건조하여 인진쑥 추출물 분말을 얻었다.
Phosphorus mugwort pulverized into 40 mesh was extracted using an ultrasonic grinder for 48 hours in a 5 times weight ratio of water or refluxed for 4 hours, and then filtered through a 0.1 to 10 μm filter if necessary, followed by 48 at a temperature of 60 to 80 ° C. Concentrated under reduced pressure for 5 times and then cooled to 30 ℃ or less extracts were freeze-dried to obtain the powder of the extract.
<< 제조예Manufacturing example 3> 다시마 추출물의 제조 3> Preparation of Kelp Extract
건조한 다시마를 1회 살수 세척하고 열풍 건조기(50℃)에서 건조한 후 121℃에서 30분간 열처리하였다. 이 후 열풍 건조기(50℃)에서 건조 하여 80 mech로 분쇄한 후 -23℃에서 냉동 보관하면서 추출시료로 사용하였다.The dried kelp was sprayed once, dried in a hot air dryer (50 ° C.), and then heat-treated at 121 ° C. for 30 minutes. Thereafter, the resultant was dried in a hot air dryer (50 ° C.), pulverized to 80 mech, and used as an extraction sample while being kept frozen at −23 ° C.
<실시예 1 내지 3><Examples 1 to 3>
상기 제조예 1 내지 3과 같은 방법으로 얻어진 다슬기 분말, 인진쑥 추출물 분말, 다시마 추출물, 그리고, 해조 칼슘 분말 (National Food, 뉴질랜드), 클로렐라 추출물 분말 (National Food, 뉴질랜드)를 각각 하기 표 1에 나타낸 비율로 혼합하여 조성물을 제조하였다.
The sage powder, phosphorus mugwort extract powder, kelp extract, and seaweed calcium powder (National Food, New Zealand) and chlorella extract powder (National Food, New Zealand) obtained by the same method as Preparation Examples 1 to 3, respectively, are shown in Table 1 below. The composition was prepared by mixing.
분말 함량(%)Mugwort Extract
Powder content (%)
함량(%)Flake powder
content(%)
함량(%)Kelp Extract
content(%)
함량(%)Chlorella
content(%)
함량(%)Seaweed calcium
content(%)
<< 실험예Experimental Example 1> 조성물 투여에 따른 성장촉진효과 1> Growth promoting effect of the composition administration
5주령의 SPF 스프라그 다울리 랫트(specified-pathogen-free Sprague-Dawley rets)를 7일간 순화시킨 후 발육이 정상이고, 건강한 랫트를 각 그룹당 암, 수 각각 5마리씩 배정하였다. Five-week-old SPF Sprague-Dawley rets were purified after 7 days of normal development, and healthy rats were assigned to 5 males and 5 males in each group.
실시예 2, 비교예 1 및 비교예 2에서 제조된 조성물을 시험군의 랫트에 각각 50mg/kg, 100mg/kg, 300mg/kg 및 500mg/kg이 되도록 물 6ml에 첨가하여 물 24ml에 섞어 매일 음수로 자유 급이시켰다. 대조군은 물만을 사용하였으며, 양성대조군에는 성장호르몬 (somatotropin)을 임상 적용 용량인 1.2mg/kg/14일을 기준으로 하여 2주마다 한번씩 피하 투여하였다. 8주 동안 시험을 수행하였으며, 성장 촉진 정도를 확인하기 위해 체중은 2주마다 측정하였고, 성장 호르몬(GH)및 인슐린-유사 성장인자-1(IGF-1)의 농도는 매달 측정하였다. 대조군과 각 투여군 사이의 유의성은 ANOVA 및 Dunnett-t 검정(Kaiyoun Cai al., Biomaterials, 23 :1153-1160(2002))으로 비교하였다. GH의 농도는 랫트 성장 호르몬 RIA 키트(Linco Res., cat. # RGH 45-HK)를 이용하여 분석하였고, IGF-1의 측정은 IRMA(immunoradiometric assay) 방법(Conti, E., et al, J. Am. Coll. Cardiol., 38, 26-32)을 이용하였다.
The compositions prepared in Example 2, Comparative Example 1 and Comparative Example 2 were added to 6 ml of water to be 50 mg / kg, 100 mg / kg, 300 mg / kg and 500 mg / kg, respectively, in the rats of the test group, mixed in 24 ml of water, and daily negative water. Freedom to feed. As a control group, only water was used, and growth hormone (somatotropin) was subcutaneously administered once every two weeks based on the clinical application dose of 1.2 mg / kg / 14 days. The test was performed for 8 weeks, body weights were measured every two weeks to determine the extent of growth promotion, and concentrations of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) were measured monthly. Significance between the control group and each dose group was compared by ANOVA and Dunnett-t assay (Kaiyoun Cai al., Biomaterials, 23: 1153-1160 (2002)). The concentration of GH was analyzed using the rat growth hormone RIA kit (Linco Res., Cat. # RGH 45-HK), and the measurement of IGF-1 was measured by immunoadiometric assay (IRMA) method (Conti, E., et al, J). Am. Coll. Cardiol., 38, 26-32).
하기 표 2 및 3 에는 각각 수컷 및 암컷의 체중 증가를, 표 4 및 5에는 GH 농도를, 표 6 및 7에는 IGF-1의 농도를 나타내었다.
Tables 2 and 3 below show male and female weight gains, Tables 4 and 5 show GH concentrations, and Tables 6 and 7 show IGF-1 concentrations.
대조군positivity
Control group
50mg/kg
투여군Example 2
50 mg / kg
Administered group
100mg/kg
투여군Example 2
100mg / kg
Administered group
300mg/kg
투여군Example 2
300 mg / kg
Administered group
500mg/kg
투여군Example 2
500mg / kg
Administered group
100mg/kg
투여군Comparative Example 1
100mg / kg
Administered group
100mg/kg
투여군Comparative Example 2
100mg / kg
Administered group
대조군positivity
Control group
50mg/kg
투여군Example 2
50 mg / kg
Administered group
100mg/kg
투여군Example 2
100mg / kg
Administered group
300mg/kg
투여군Example 2
300 mg / kg
Administered group
500mg/kg
투여군Example 2
500mg / kg
Administered group
100mg/kg
투여군Comparative Example 1
100mg / kg
Administered group
100mg/kg
투여군Comparative Example 2
100mg / kg
Administered group
상기 표 2 및 3에서 보듯이, 대조군의 수컷과 암컷의 체중 증가율은 각각 46.2% 및 36%이었으며, 성장호르몬을 투여한 양성 대조군의 경우 50.4% 및 40.7% 증가함으로써 대조군의 증가율에 비하여 4~5% 높은 증가율을 나타내었다. 또한, 본 발명의 조성물을 투여한 경우 대조군의 증가율과 비교하여 3~6% 높은 증가율을 보여 기존의 성장호르몬과 동등한 효과를 나타냄을 알 수 있다.
As shown in Tables 2 and 3, the weight gain rates of males and females of the control group were 46.2% and 36%, respectively. In the positive control group to which growth hormone was administered, 50.4% and 40.7% of the control group increased 4 to 5 compared to the control group. % Increased rate. In addition, it can be seen that the administration of the composition of the present invention shows an increase rate of 3 to 6% compared to the increase rate of the control group shows an effect equivalent to the existing growth hormone.
투여군50 mg / kg
Administered group
투여군100mg / kg
Administered group
투여군300 mg / kg
Administered group
투여군500mg / kg
Administered group
투여군50 mg / kg
Administered group
투여군100mg / kg
Administered group
투여군300 mg / kg
Administered group
투여군500mg / kg
Administered group
상기 표 4 및 5에서 보듯이, 양성 대조군의 경우 성장 호르몬 양의 증가율이 대조군에서의 성장 호르몬 양의 증가율에 비해 11~20% 높게 나타났다. 또한 본 발명의 조성물을 투여한 경우에는 대조군의 성장 호르몬 양의 증가율에 비하여 7~17% 높게 나타났으며, 이는 양성 대조군보다도 우수한 결과임을 알 수 있다. 또한 성장 호르몬과 조성물의 양은 비례적인 관계를 가지고 있지 않지만, 수컷과 암컷 모두 300 mg/kg의 조성물 농도에서 가장 좋은 결과를 나타냄을 알 수 있다.
As shown in Tables 4 and 5, the growth rate of the growth hormone amount in the positive control group was 11 ~ 20% higher than the growth rate of the growth hormone amount in the control group. In addition, when the composition of the present invention was administered, 7 ~ 17% higher than the increase rate of the growth hormone amount of the control group, which can be seen that the better results than the positive control group. In addition, the growth hormone and the amount of the composition does not have a proportional relationship, but both males and females can be seen that the best results at a composition concentration of 300 mg / kg.
투여군50 mg / kg
Administered group
투여군100mg / kg
Administered group
투여군300 mg / kg
Administered group
투여군500mg / kg
Administered group
투여군50 mg / kg
Administered group
투여군100mg / kg
Administered group
투여군300 mg / kg
Administered group
투여군500mg / kg
Administered group
상기 표 6 및 7에서 보듯이, IGF-1의 경우도 성장 호르몬과 마찬가지로 300mg/kg의 조성물 투여군에서 가장 좋은 효과를 보임을 볼 수 있었다.
As shown in Tables 6 and 7, IGF-1 also showed the best effect in the composition-administered group of 300 mg / kg as well as growth hormone.
Claims (3)
It contains 5 times 20% by weight of kelp extract, 5-20% by weight of kelp extract, 20-30% by weight of 100% by weight of the total weight of the composition. Composition for promoting growth and development of children and adolescents, characterized in that it comprises 20% 30% by weight of the extract, 20-30% by weight of chlorella, 20-30% by weight of seaweed calcium.
The extract according to claim 1, the extract of the mountain extract, Ogapi extract, malt extract, dermis extract, nabokja extract, tanza extract, Schisandra chinensis extract, Bokbunja extract, longan extract, Angelica extract, sesame extract, Chinese quince extract, soy extract , Gilgei extract, jujube extract, licorice extract, peppermint extract, a composition for promoting growth and growth of children and adolescents, characterized in that it further comprises one or more components selected from dried extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120074139A KR101252630B1 (en) | 2012-07-06 | 2012-07-06 | Useful composition for growth and development of children and youths |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120074139A KR101252630B1 (en) | 2012-07-06 | 2012-07-06 | Useful composition for growth and development of children and youths |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101252630B1 true KR101252630B1 (en) | 2013-04-09 |
Family
ID=48442747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120074139A KR101252630B1 (en) | 2012-07-06 | 2012-07-06 | Useful composition for growth and development of children and youths |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101252630B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104544031A (en) * | 2013-10-25 | 2015-04-29 | 杨虎 | Simple processing method of domestic infant formula food |
KR20150083638A (en) * | 2014-01-10 | 2015-07-20 | 주식회사 설악바이오 | Composition for enhancing growth and reinforcing immunity |
WO2015147559A1 (en) * | 2014-03-28 | 2015-10-01 | (주)솔빛피앤에프 | Composition for promoting growth comprising chaenomeles sinesis as active ingredient |
KR101639317B1 (en) | 2015-04-14 | 2016-07-13 | 주식회사 브릿지오브날리지 | Useful composition for growth of children |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040036272A (en) * | 2002-10-24 | 2004-04-30 | 알앤엘생명과학주식회사 | A composition for promoting growth or secretion of growth hormone comprising an extract of artemisia capillaris thunberg. and functional cereals coated by same |
KR20040091418A (en) * | 2003-04-21 | 2004-10-28 | 조찬휘 | Method for manufacturing melanian snail extract and functional food having the extract |
KR20080110129A (en) * | 2007-06-14 | 2008-12-18 | 유한회사 메디핌 | Food composition for stimulating growth by balancing between nutritional ingredient and growth stimulating ingredient |
-
2012
- 2012-07-06 KR KR1020120074139A patent/KR101252630B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040036272A (en) * | 2002-10-24 | 2004-04-30 | 알앤엘생명과학주식회사 | A composition for promoting growth or secretion of growth hormone comprising an extract of artemisia capillaris thunberg. and functional cereals coated by same |
KR20040091418A (en) * | 2003-04-21 | 2004-10-28 | 조찬휘 | Method for manufacturing melanian snail extract and functional food having the extract |
KR20080110129A (en) * | 2007-06-14 | 2008-12-18 | 유한회사 메디핌 | Food composition for stimulating growth by balancing between nutritional ingredient and growth stimulating ingredient |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104544031A (en) * | 2013-10-25 | 2015-04-29 | 杨虎 | Simple processing method of domestic infant formula food |
KR20150083638A (en) * | 2014-01-10 | 2015-07-20 | 주식회사 설악바이오 | Composition for enhancing growth and reinforcing immunity |
KR101642176B1 (en) | 2014-01-10 | 2016-07-22 | 주식회사 설악바이오 | Composition for enhancing growth and reinforcing immunity |
WO2015147559A1 (en) * | 2014-03-28 | 2015-10-01 | (주)솔빛피앤에프 | Composition for promoting growth comprising chaenomeles sinesis as active ingredient |
KR101639317B1 (en) | 2015-04-14 | 2016-07-13 | 주식회사 브릿지오브날리지 | Useful composition for growth of children |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103141709B (en) | Carp feed and preparation method thereof | |
CN102813064B (en) | Plant extract feed additive for piglets | |
CN103704623B (en) | A kind of agate card fermented nutrient food | |
CN102599322A (en) | Tablet candy suitable for children and manufacturing method thereof | |
CN103493941A (en) | Weight-reducing and health-protecting tea and preparation method thereof | |
CN108618126A (en) | A kind of Chinese medicine compound prescription weight-reducing special diet food and preparation method thereof | |
KR101252630B1 (en) | Useful composition for growth and development of children and youths | |
CN106173548A (en) | One carp feed in autumn | |
KR20160117034A (en) | Composition for improving sexual functionality having effects of increasing of the number of sperm and protection of environmental hormone and manufacturing method thereof | |
CN102823871A (en) | Health care product for promoting lead removal and preparation method thereof | |
KR20080110129A (en) | Food composition for stimulating growth by balancing between nutritional ingredient and growth stimulating ingredient | |
KR100800359B1 (en) | A composition having depilation preventing and trichogenousness effect | |
KR100643596B1 (en) | Additive for feed and feed comprising it | |
KR100509983B1 (en) | Healthy food composition for accelerating growth | |
CN106074655A (en) | Nanoscale Eurycoma longifolia and the preparation method of Maca mixed extract | |
CN106387451A (en) | Traditional Chinese medicine additive for promoting growth and development of weaned lambs and feed including traditional Chinese medicine additive | |
CN105030858A (en) | Cynomorium songaricum healthcare tablet and preparation method thereof | |
KR100278206B1 (en) | Health supplement composition for growth | |
CN105981941A (en) | Selenium-enriched pig feed and raising method of selenium-enriched pigs | |
KR100902947B1 (en) | Composition Containing Culture of Bacillus subtilis MORI for Growth Promotion | |
CN108186966A (en) | A kind of composition for preventing or improving senile dementia and its application | |
CN101366422A (en) | Cordyceps sinensis bag tea and method of preparing the same | |
KR101316731B1 (en) | Lipolysis Promoter and Food-and-drink and Feed Containing the Same | |
JP2004321087A (en) | Healthy food and method for producing the same | |
CN111758809A (en) | Astragalus membranaceus and samara leaf health-care tea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170328 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20180403 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20190131 Year of fee payment: 7 |
|
R401 | Registration of restoration |